Stay updated on BTX 1204 Safety in Moderate Atopic Dermatitis Clinical Trial

Sign up to get notified when there's something new on the BTX 1204 Safety in Moderate Atopic Dermatitis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the BTX 1204 Safety in Moderate Atopic Dermatitis Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    No significant additions or deletions were detected on the Study Details page for NCT03824405; the core information remains unchanged.
    Difference
    0.4%
    Check dated 2025-10-27T21:05:53.000Z thumbnail image
  3. Check
    33 days ago
    Change Detected
    Summary
    Major change: page now carries a government-operating-status notice and a new version tag (v3.2.0) replacing the old one (v3.1.0).
    Difference
    3%
    Check dated 2025-10-06T08:25:30.000Z thumbnail image
  4. Check
    40 days ago
    Change Detected
    Summary
    Changed the revision from v3.0.2 to v3.1.0, indicating a minor version update with no other content changes.
    Difference
    0.1%
    Check dated 2025-09-29T05:07:28.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    Revision bumped from v3.0.1 to v3.0.2. No substantive content changes; a minor UI element ('Back to Top') was removed.
    Difference
    0.2%
    Check dated 2025-09-14T23:12:57.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.
    Difference
    0.2%
    Check dated 2025-09-07T19:52:10.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    The web page has updated its facility name and location details, specifically replacing the previous mention of 'Saint Louis, Missouri' with 'St Louis, Missouri, United States, 63141', and has added new medical topics related to congenital and skin diseases.
    Difference
    3%
    Check dated 2025-08-31T12:29:06.000Z thumbnail image

Stay in the know with updates to BTX 1204 Safety in Moderate Atopic Dermatitis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the BTX 1204 Safety in Moderate Atopic Dermatitis Clinical Trial page.